🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
CONTESSA 2 is a multinational, multicenter, Phase 2 study of tesetaxel in p...
Status
Terminated
Location
Innovative Clinical Research Institute
Start Date
2019-02-05
Trial ID
NCT03858972
Treatments Being Tested
This study is being conducted to compare the efficacy and safety of tesetax...
Status
Unknown
Location
The West Clinic
Start Date
2012-05
Trial ID
NCT01609127
Treatments Being Tested
This study is being performed to evaluate the efficacy and safety of capeci...
Status
Unknown
Location
The University of Texas MD Anderson Cancer Center
Start Date
2012-04
Trial ID
NCT01573468
Treatments Being Tested
CONTESSA is a multinational, multicenter, randomized, Phase 3 study of tese...
Status
Terminated
Location
Ironwood Cancer and Research Centers
Start Date
2017-12-21
Trial ID
NCT03326674
Treatments Being Tested
Cisplatin, an intravenously administered platinum agent, in combination wit...
Status
Unknown
Location
Yonsei Cancer Center, Yonsei University College of Medicine
Start Date
2011-05
Trial ID
NCT01348009
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as DJ-927 and capecitabine, use...
Status
Completed
Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Start Date
2004-02
Trial ID
NCT00077077
Treatments Being Tested
This study is being performed to confirm the safety of tesetaxel 27 mg/m2 (...
Status
Unknown
Location
The West Clinic
Start Date
2011-03
Trial ID
NCT01315431
Treatments Being Tested